| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | WD40_repeat_dom | 1.16e-03 | 297 | 50 | 5 | IPR017986 | |
| Domain | Cupredoxin | 1.57e-03 | 22 | 50 | 2 | IPR008972 | |
| Domain | GPS | 3.73e-03 | 34 | 50 | 2 | SM00303 | |
| Domain | GPS | 3.95e-03 | 35 | 50 | 2 | PF01825 | |
| Domain | GPS | 4.18e-03 | 36 | 50 | 2 | PS50221 | |
| Domain | GPS | 4.41e-03 | 37 | 50 | 2 | IPR000203 | |
| Domain | Pkinase_C | 4.41e-03 | 37 | 50 | 2 | IPR017892 | |
| Domain | WD40 | 5.05e-03 | 259 | 50 | 4 | PF00400 | |
| Domain | Pkinase_C | 5.65e-03 | 42 | 50 | 2 | PF00433 | |
| Domain | WD40 | 5.69e-03 | 268 | 50 | 4 | SM00320 | |
| Domain | WD40_repeat | 5.99e-03 | 272 | 50 | 4 | IPR001680 | |
| Domain | WD_REPEATS_1 | 6.47e-03 | 278 | 50 | 4 | PS00678 | |
| Domain | WD_REPEATS_2 | 6.55e-03 | 279 | 50 | 4 | PS50082 | |
| Domain | WD_REPEATS_REGION | 6.55e-03 | 279 | 50 | 4 | PS50294 | |
| Domain | AGC-kinase_C | 9.86e-03 | 56 | 50 | 2 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 9.86e-03 | 56 | 50 | 2 | PS51285 | |
| Pubmed | LPIN3 COPB2 STK38 MRPL45 CDC5L PRPF8 CMAS STK38L ADGRD1 RRP1 COL1A1 | 8.80e-07 | 1153 | 52 | 11 | 29845934 | |
| Pubmed | 1.62e-06 | 383 | 52 | 7 | 29331416 | ||
| Pubmed | NDR functions as a physiological YAP1 kinase in the intestinal epithelium. | 2.19e-06 | 2 | 52 | 2 | 25601544 | |
| Pubmed | Nociceptor-expressed ephrin-B2 regulates inflammatory and neuropathic pain. | 2.19e-06 | 2 | 52 | 2 | 21059214 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 15037617 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 3.93e-06 | 1082 | 52 | 10 | 38697112 | |
| Pubmed | Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease. | 5.84e-06 | 78 | 52 | 4 | 19204726 | |
| Pubmed | Human NDR kinases control G(1)/S cell cycle transition by directly regulating p21 stability. | 6.57e-06 | 3 | 52 | 2 | 21262772 | |
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 23897809 | ||
| Pubmed | HIV-1 incorporates and proteolytically processes human NDR1 and NDR2 serine-threonine kinases. | 6.57e-06 | 3 | 52 | 2 | 15582665 | |
| Pubmed | 8.26e-06 | 320 | 52 | 6 | 28685749 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | 1.27e-05 | 974 | 52 | 9 | 28675297 | |
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 19062280 | ||
| Pubmed | Mechanism of activation of NDR (nuclear Dbf2-related) protein kinase by the hMOB1 protein. | 1.31e-05 | 4 | 52 | 2 | 15197186 | |
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 25848867 | ||
| Pubmed | 1.66e-05 | 547 | 52 | 7 | 37267103 | ||
| Pubmed | Ndr kinases regulate retinal interneuron proliferation and homeostasis. | 2.19e-05 | 5 | 52 | 2 | 30135513 | |
| Pubmed | 2.19e-05 | 5 | 52 | 2 | 26258302 | ||
| Pubmed | Human Mob proteins regulate the NDR1 and NDR2 serine-threonine kinases. | 2.19e-05 | 5 | 52 | 2 | 15067004 | |
| Pubmed | Control of cardiac jelly dynamics by NOTCH1 and NRG1 defines the building plan for trabeculation. | 2.56e-05 | 38 | 52 | 3 | 29743679 | |
| Pubmed | Loss of NDR1/2 kinases impairs endomembrane trafficking and autophagy leading to neurodegeneration. | 3.28e-05 | 6 | 52 | 2 | 36446521 | |
| Pubmed | 3.28e-05 | 6 | 52 | 2 | 17179726 | ||
| Pubmed | 3.44e-05 | 613 | 52 | 7 | 22268729 | ||
| Pubmed | 5.32e-05 | 657 | 52 | 7 | 36180527 | ||
| Pubmed | The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis. | 6.02e-05 | 141 | 52 | 4 | 32322062 | |
| Pubmed | 6.07e-05 | 1487 | 52 | 10 | 33957083 | ||
| Pubmed | S. aureus drives itch and scratch-induced skin damage through a V8 protease-PAR1 axis. | 6.10e-05 | 8 | 52 | 2 | 37995657 | |
| Pubmed | Unconventional molecular regulation of synaptic vesicle replenishment in cochlear inner hair cells. | 6.10e-05 | 8 | 52 | 2 | 25609709 | |
| Pubmed | 6.10e-05 | 8 | 52 | 2 | 20595234 | ||
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | 9.75e-05 | 498 | 52 | 6 | 36634849 | |
| Pubmed | 1.20e-04 | 11 | 52 | 2 | 34927784 | ||
| Pubmed | Macrophages transfer mitochondria to sensory neurons to resolve inflammatory pain. | 1.20e-04 | 11 | 52 | 2 | 34921782 | |
| Pubmed | 1.20e-04 | 322 | 52 | 5 | 26514267 | ||
| Pubmed | The cellular EJC interactome reveals higher-order mRNP structure and an EJC-SR protein nexus. | 1.21e-04 | 169 | 52 | 4 | 23084401 | |
| Pubmed | 1.29e-04 | 65 | 52 | 3 | 29150431 | ||
| Pubmed | 1.40e-04 | 333 | 52 | 5 | 36779763 | ||
| Pubmed | Hepatic transferrin plays a role in systemic iron homeostasis and liver ferroptosis. | 1.69e-04 | 13 | 52 | 2 | 32374849 | |
| Pubmed | Loss of flow responsive Tie1 results in Impaired Aortic valve remodeling. | 1.97e-04 | 14 | 52 | 2 | 31319059 | |
| Pubmed | 2.57e-04 | 1440 | 52 | 9 | 30833792 | ||
| Pubmed | 2.60e-04 | 16 | 52 | 2 | 25300579 | ||
| Pubmed | Ski regulates Hippo and TAZ signaling to suppress breast cancer progression. | 2.76e-04 | 84 | 52 | 3 | 25670202 | |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | 2.84e-04 | 607 | 52 | 6 | 39147351 | |
| Pubmed | 2.94e-04 | 17 | 52 | 2 | 18559979 | ||
| Pubmed | 3.16e-04 | 217 | 52 | 4 | 30619736 | ||
| Pubmed | Jumonji modulates polycomb activity and self-renewal versus differentiation of stem cells. | 3.30e-04 | 18 | 52 | 2 | 20064376 | |
| Pubmed | FAF1 phosphorylation by AKT accumulates TGF-β type II receptor and drives breast cancer metastasis. | 3.56e-04 | 224 | 52 | 4 | 28443643 | |
| Pubmed | Gene essentiality and synthetic lethality in haploid human cells. | 3.87e-04 | 229 | 52 | 4 | 26472760 | |
| Pubmed | 3.96e-04 | 417 | 52 | 5 | 36537216 | ||
| Pubmed | Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics. | 4.18e-04 | 422 | 52 | 5 | 27342126 | |
| Pubmed | 4.20e-04 | 234 | 52 | 4 | 36243803 | ||
| Pubmed | 4.52e-04 | 21 | 52 | 2 | 12840015 | ||
| Pubmed | 5.37e-04 | 446 | 52 | 5 | 24255178 | ||
| Pubmed | 5.44e-04 | 23 | 52 | 2 | 30814516 | ||
| Pubmed | Genome-wide Identification of Foxf2 Target Genes in Palate Development. | 5.44e-04 | 23 | 52 | 2 | 32040930 | |
| Pubmed | 5.44e-04 | 23 | 52 | 2 | 26027930 | ||
| Pubmed | 6.02e-04 | 1285 | 52 | 8 | 35914814 | ||
| Pubmed | 6.57e-04 | 113 | 52 | 3 | 30352685 | ||
| Pubmed | 6.96e-04 | 26 | 52 | 2 | 31138536 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 7.83e-04 | 736 | 52 | 6 | 29676528 | |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | 7.90e-04 | 486 | 52 | 5 | 30940648 | |
| Pubmed | 8.08e-04 | 28 | 52 | 2 | 17683524 | ||
| Pubmed | Obesity and diabetes genetic variants associated with gestational weight gain. | 8.67e-04 | 29 | 52 | 2 | 20816152 | |
| Pubmed | Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins. | 8.89e-04 | 499 | 52 | 5 | 22810586 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | 9.01e-04 | 1367 | 52 | 8 | 32687490 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 9.18e-04 | 759 | 52 | 6 | 35915203 | |
| Pubmed | 9.29e-04 | 30 | 52 | 2 | 36460641 | ||
| Pubmed | Cryo-EM structure of a human spliceosome activated for step 2 of splicing. | 9.29e-04 | 30 | 52 | 2 | 28076346 | |
| Pubmed | 1.12e-03 | 33 | 52 | 2 | 19834762 | ||
| Pubmed | 1.14e-03 | 306 | 52 | 4 | 18973680 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | 1.18e-03 | 1425 | 52 | 8 | 30948266 | |
| Pubmed | A SOX17-PDGFB signaling axis regulates aortic root development. | 1.19e-03 | 34 | 52 | 2 | 35831318 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | 1.26e-03 | 807 | 52 | 6 | 30575818 | |
| Pubmed | 1.26e-03 | 35 | 52 | 2 | 23716698 | ||
| Pubmed | Galnt1 is required for normal heart valve development and cardiac function. | 1.34e-03 | 36 | 52 | 2 | 25615642 | |
| Pubmed | Nuclear Functions of Nucleolin through Global Proteomics and Interactomic Approaches. | 1.35e-03 | 145 | 52 | 3 | 27049334 | |
| Cytoband | 15q21.2 | 5.01e-04 | 29 | 52 | 2 | 15q21.2 | |
| Cytoband | 6p21 | 1.93e-03 | 57 | 52 | 2 | 6p21 | |
| GeneFamily | WD repeat domain containing | 1.76e-03 | 262 | 36 | 4 | 362 | |
| GeneFamily | CD molecules|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing | 3.16e-03 | 42 | 36 | 2 | 602 | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 8.26e-08 | 187 | 52 | 6 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | LV-10._Endothelium_II|LV / Chamber and Cluster_Paper | 1.03e-07 | 194 | 52 | 6 | b6cc849fa08599bff9839ef382d190cc964e273e | |
| ToppCell | CV-Healthy-7|Healthy / Virus stimulation, Condition and Cluster | 2.47e-06 | 185 | 52 | 5 | 1979d189c204f4c2893e3170a514ee7d5523406c | |
| ToppCell | COVID-19-Endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.82e-06 | 190 | 52 | 5 | 9fbd92cd6d4683b2490504d29c43cf42020433d4 | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 3.04e-06 | 193 | 52 | 5 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 3.04e-06 | 193 | 52 | 5 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell-Mesothelium-Mesothelium_L.2.6.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.12e-06 | 194 | 52 | 5 | 421344cc4b601d9745fa72d0af3124dab11d1d27 | |
| ToppCell | COVID-19-lung-Capillary_1|lung / Disease (COVID-19 only), tissue and cell type | 3.36e-06 | 197 | 52 | 5 | 7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4 | |
| ToppCell | COVID-19-lung-Capillary_2|lung / Disease (COVID-19 only), tissue and cell type | 3.53e-06 | 199 | 52 | 5 | 793ce71b78a68033ef4419ed571e1dd86b40124f | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Mesothelial-1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 3.62e-06 | 200 | 52 | 5 | bf50e30d5cafb71c567e89580f62084d2f894170 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Mesothelial-1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.62e-06 | 200 | 52 | 5 | 5e5ad07679d5dd2ca80249bce9aaf4a95d42187b | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Mesothelial-1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.62e-06 | 200 | 52 | 5 | c800f20adedf4ca736c740510889e92d8bf0ba44 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-8|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 4.42e-05 | 168 | 52 | 4 | 00646601548b0fee42ae16bfa5e93603bc7c5129 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.95e-05 | 173 | 52 | 4 | 30d67738633493d47f06ae452424382f069b6c0a | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.06e-05 | 174 | 52 | 4 | a9c6edf5c3fc119c24425f921c5566a8356c30fe | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.41e-05 | 177 | 52 | 4 | 1d5a071157c755f3a27a5c3143015da04ee0b0dc | |
| ToppCell | 10x5'-Lung-Lymphocytic_B_plasma-Plasmablasts|Lung / Manually curated celltypes from each tissue | 5.65e-05 | 179 | 52 | 4 | 3fa75eec3e86fd1797eaa33362257df7f9b2a0bf | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_myocytic|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.90e-05 | 181 | 52 | 4 | 47dce04db3392333eb2f7b9b24c32e6740d2d02f | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_myocytic-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.90e-05 | 181 | 52 | 4 | 19103221c3a5a16b16378348004b2c50caee4f01 | |
| ToppCell | 21-Trachea-Mesenchymal-Mesenchyme_SERPINF1-high|Trachea / Age, Tissue, Lineage and Cell class | 6.03e-05 | 182 | 52 | 4 | 354dcdb01360597f68c4fe157a682aee1c0b8bb1 | |
| ToppCell | CV-Healthy-7|CV / Virus stimulation, Condition and Cluster | 6.29e-05 | 184 | 52 | 4 | 0e5cc77aaa73ceb791f8be7456177577fd2e5586 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.42e-05 | 185 | 52 | 4 | 7dcdc009c5681ee05dd18968f7e85c3403fe34af | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 6.98e-05 | 189 | 52 | 4 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(general)|COVID-19 / group, cell type (main and fine annotations) | 7.12e-05 | 190 | 52 | 4 | 812e11314c76c0179fbe5a9bea29b41ce5cbc93d | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.27e-05 | 191 | 52 | 4 | 2f00d0b7b2ffce8eb3eb5bbae49a0d425b23c982 | |
| ToppCell | IPF-Endothelial-VE_Venous|IPF / Disease state, Lineage and Cell class | 7.56e-05 | 193 | 52 | 4 | 29a655fa80feaabe846c90a28363b037e22d24ae | |
| ToppCell | IPF-Endothelial-VE_Capillary_B|World / Disease state, Lineage and Cell class | 7.56e-05 | 193 | 52 | 4 | d7750a7575ef257963b7f1c64fa67c52dbff797b | |
| ToppCell | COPD-Endothelial|COPD / Disease state, Lineage and Cell class | 7.56e-05 | 193 | 52 | 4 | 093b28dcccb5841c995d0b33fae0efd6b88f97e0 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-B_(Artery)|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.72e-05 | 194 | 52 | 4 | f8a59bd4609d147d8a706bf606e9e8173c9992a3 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.72e-05 | 194 | 52 | 4 | 79baee8b35b7707bbeb07c73b5e17b68bcd7bbc2 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibro-meso|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.72e-05 | 194 | 52 | 4 | f6e348f1f35c526cad6c349f1fdd0bd92d18aa3c | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|COPD / Disease state, Lineage and Cell class | 7.72e-05 | 194 | 52 | 4 | 18b7f901c12ca4f21f9a1eafd092aefe4d668b6d | |
| ToppCell | 390C-Endothelial_cells-Endothelial-B_(Artery)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.72e-05 | 194 | 52 | 4 | 04b1acc2e879feafb43f75435281c5acd8d23be2 | |
| ToppCell | Adult-Endothelial|Adult / Lineage, Cell type, age group and donor | 7.72e-05 | 194 | 52 | 4 | 963b3fbee0575af8379baa397ace65949eaf34f7 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell-Mesothelium|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.72e-05 | 194 | 52 | 4 | ce599ed0dc181aea0584e426636de5098f34ebe6 | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|World / Disease state, Lineage and Cell class | 7.72e-05 | 194 | 52 | 4 | 68705a6eca947c5b42b943d5224a7aef2a744007 | |
| ToppCell | IPF-Endothelial-VE_Capillary_B|IPF / Disease state, Lineage and Cell class | 7.72e-05 | 194 | 52 | 4 | 169a304d5c13f08c39fad4116f093bc4a0765e9d | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Subpleural_fibroblasts-Subpleural_fibroblasts_L.2.1.5.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.87e-05 | 195 | 52 | 4 | 0866aaf053762d1a021fcbccff058526078a99da | |
| ToppCell | COVID-19-lung-Capillary_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.35e-05 | 198 | 52 | 4 | 45419f2804b4be79bae6632e71c54e1af482d115 | |
| ToppCell | normal_Lung-Endothelial_cells-Stalk-like_ECs|normal_Lung / Location, Cell class and cell subclass | 8.35e-05 | 198 | 52 | 4 | 2a251d13c2488d15ca9b11e643c1d17d428b6ef0 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.51e-05 | 199 | 52 | 4 | 6a2943a23fdd2ec814662db7c21a0d6804a6cbbc | |
| ToppCell | Bronchial-10x5prime-Endothelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.68e-05 | 200 | 52 | 4 | ad34c978cc6b89b4c1c8c9b2fb2a938051b555a0 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1--L4-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.68e-05 | 200 | 52 | 4 | 4a426ef88376d8bb2b9dc50aa06e7b9fc50ecc9c | |
| ToppCell | Parenchymal-10x5prime-Endothelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.68e-05 | 200 | 52 | 4 | 0e648e9eb96c83a94505d07323785a7a40997eb0 | |
| ToppCell | Biopsy_IPF-Endothelial-Endothelial_cells|Biopsy_IPF / Sample group, Lineage and Cell type | 8.68e-05 | 200 | 52 | 4 | 39b4faad5700b3108f851f0df7fea3d298514465 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuroepithelial-Proteoglycan-expressing_cell|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 8.68e-05 | 200 | 52 | 4 | da45a85a4667965b24ba824af871157af5b4cd19 | |
| ToppCell | Biopsy_IPF-Endothelial|Biopsy_IPF / Sample group, Lineage and Cell type | 8.68e-05 | 200 | 52 | 4 | 7ccd3b617838b39da814278dc0e12384013401ce | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuroepithelial|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 8.68e-05 | 200 | 52 | 4 | 25f4c051c2e869481f33c22ad54de97efac444ad | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.68e-05 | 200 | 52 | 4 | fbeee1c16ac0a7fe28d90491c8b079f21ce80bdc | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.68e-05 | 200 | 52 | 4 | c6eda342ea0cb37d71d89dbb8d11e819e0745172 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal-Mesothelium|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.68e-05 | 200 | 52 | 4 | c082bc21ec7c5323439d108ea8aea510e1113c3f | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.68e-05 | 200 | 52 | 4 | 6a3ccd0ea742fa76282c2b0fbc59942b4ef47bb8 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_VISp_Rrad|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.59e-04 | 138 | 52 | 3 | b3a040c5d0e1cc94d9b19155bca8700edba2d243 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Dendritic-conventional_dendritic_cell-DC_c3-LAMP3|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.71e-04 | 139 | 52 | 3 | bb2b020dda32ddc60ec9952de5b01acee60b5b59 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_104|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.26e-04 | 151 | 52 | 3 | ea62e92ccb984f44559b434f35c1c4450767c8f1 | |
| ToppCell | facs-Spleen-nan-24m-Myeloid|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.98e-04 | 156 | 52 | 3 | 034d4359359a44c205c6931f38a375271ac2752b | |
| ToppCell | facs-Spleen-nan-24m-Myeloid-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.98e-04 | 156 | 52 | 3 | 2a4dac4100c0339aad4905b8eaca6e8fe806718b | |
| ToppCell | facs-Spleen-nan-24m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.98e-04 | 156 | 52 | 3 | 21267718d3a3dc19988663b6846aed8bb3eae836 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.98e-04 | 156 | 52 | 3 | 363f1b661048d25895e2b8681c82894c957b29c0 | |
| ToppCell | droplet-Fat-Mat-18m-Epithelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.98e-04 | 156 | 52 | 3 | f09150aacb6121f913648ed3918f9cd4f22c61f2 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.98e-04 | 156 | 52 | 3 | d5207dbfbcfb885557ea1378dfe6a56d7102e94a | |
| ToppCell | droplet-Fat-Mat-18m-Epithelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.98e-04 | 156 | 52 | 3 | cfd7f56f3155db677684827607e9008e975dbe70 | |
| ToppCell | droplet-Fat-Mat-18m-Epithelial-epithelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.98e-04 | 156 | 52 | 3 | 0d79b4172896574b00faf00e87254f68d76f5512 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.58e-04 | 160 | 52 | 3 | 8624f101828efd32cdd38a65df8d94d690720a63 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.58e-04 | 160 | 52 | 3 | 9de3dd6b9d4b51314d60b3b01f4132bcfa2dfc18 | |
| ToppCell | Club-club-13|World / Class top | 8.90e-04 | 162 | 52 | 3 | 7d18f05a65ac715e62d610df9cc4a26539340dee | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.90e-04 | 162 | 52 | 3 | bc63a96ad3ba0b3433e3679d7a005f47709ff384 | |
| ToppCell | droplet-Spleen-nan-18m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.06e-04 | 163 | 52 | 3 | bc37c5d9f48b16096d5313657563f3ec84028c8c | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_bronchial_vessel-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.06e-04 | 163 | 52 | 3 | ba7d02db0f0e2f9916ec8db52c067c87b6917c23 | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D231|Adult / Lineage, Cell type, age group and donor | 9.22e-04 | 164 | 52 | 3 | 2ba57dce5f69a88f0d1e450b9780425e2d9ca7d4 | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.38e-04 | 165 | 52 | 3 | b671c6a950e70f64776c2104baccb3dc2bb6a1ba | |
| ToppCell | Endothelial-endothelial_cell_of_bronchial_vessel|World / Lineage, Cell type, age group and donor | 9.38e-04 | 165 | 52 | 3 | 84e553d699ac56df89a77248f7308b9133e1b683 | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.88e-04 | 168 | 52 | 3 | 03896466698a79f7f1ad862cb7e05585260e2a5a | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.01e-03 | 169 | 52 | 3 | 01a24a8817628125bd004b2be68ffa62c7111f6e | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-Enterocyte|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-03 | 171 | 52 | 3 | b0d616699e2110ffd6cf1868ed1f1a29f824e1fc | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-03 | 171 | 52 | 3 | e7dbee63cc39230aa12e7868ec78a129160c0d22 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-03 | 172 | 52 | 3 | 3f784aed340b50ddbec3f7dc0a5279180d38a2bb | |
| ToppCell | droplet-Large_Intestine-COLON_-_"PROM_Tm"-30m-Epithelial-Enterocyte|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-03 | 176 | 52 | 3 | ce950805aaa3d39630376028ecd7da584fdb4394 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.13e-03 | 176 | 52 | 3 | 8e7f38de8bf68077e2138f4d06c1f55b0fd096cc | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.13e-03 | 176 | 52 | 3 | ed575330a08a6748ea4b28433292c8cfd157d444 | |
| ToppCell | droplet-Large_Intestine-COLON_-_"PROM_Tm"-30m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-03 | 176 | 52 | 3 | 5b65693833e02c08530488cbe37883e7c75f312e | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_macrophage-stroma-erythroid_macrophage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.15e-03 | 177 | 52 | 3 | b647667da62a91dbe3890820142626e26aa779d2 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.15e-03 | 177 | 52 | 3 | 30f82b04e48940bfcaf2c22677efe6d57ae3f1a7 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.17e-03 | 178 | 52 | 3 | 8f31b3fac51591f7f2bcb898c07708b3e9f93a16 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Fibcd1-Excitatory_Neuron.Slc17a7.Fibcd1-Grm5_(CA1_Principal_cells)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.20e-03 | 44 | 52 | 2 | 598044d7c325bc48ac8ab0c0722b4bb263028d71 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.20e-03 | 180 | 52 | 3 | 755050226eeb1991ee7f0d15e39d0458f3e4a791 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.20e-03 | 180 | 52 | 3 | 8f774dcacc1626e4e6492f1eb927b0ed56fbe686 | |
| ToppCell | COVID-19-kidney-PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.20e-03 | 180 | 52 | 3 | 493cf8d1a8f2a1ed2672f394a0338b110fd81d88 | |
| ToppCell | PBMC-Convalescent-Hematopoietic-Platelet-Platelet-plt_1|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.20e-03 | 180 | 52 | 3 | 3c605d6adb4199963532f3639f2c768f7e575152 | |
| ToppCell | PBMC-Convalescent-Hematopoietic-Platelet-Platelet-plt_1|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.20e-03 | 180 | 52 | 3 | 3d52ca0568f9c0d6359b302ff5ff41b075f78597 | |
| ToppCell | P28-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.20e-03 | 180 | 52 | 3 | 9adebde5f4ca6dcb90e9113622862e14298465ac | |
| ToppCell | COVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.22e-03 | 181 | 52 | 3 | c5f9c92af1384d9089c65afdf41c6feb8345a3ae | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.22e-03 | 181 | 52 | 3 | bd7e9437839bca543ca5945df43d6525e6a312a8 | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(other)|COVID-19 / group, cell type (main and fine annotations) | 1.22e-03 | 181 | 52 | 3 | 26eb4ee57a70dbf54e096b73129fda9dfda1f6ec | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC-cycling_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.22e-03 | 181 | 52 | 3 | 4a225d9a6d113396c6b1d0a839bb4ca9c339a260 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.24e-03 | 182 | 52 | 3 | e9fcae9d03a6faf85b91882c5da699037bc61aeb | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.24e-03 | 182 | 52 | 3 | a3c5c0eff527c8d3848acda14af8f9e99c69b0de | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.26e-03 | 183 | 52 | 3 | 6f8f997ffc9eaebca2683de125b6069d07c07d26 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.26e-03 | 183 | 52 | 3 | d2074b13b4831ec18c81273d9a1ff673c3f6a16d | |
| ToppCell | COPD-Epithelial-ATII|World / Disease state, Lineage and Cell class | 1.26e-03 | 183 | 52 | 3 | 8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9 | |
| Drug | Delcorine; Down 200; 8.4uM; MCF7; HT_HG-U133A | 4.92e-06 | 196 | 51 | 6 | 3613_DN | |
| Drug | 75 v | 4.92e-06 | 2 | 51 | 2 | CID005494398 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| WMSKCGADWEEYIKM | 311 | Q9H993 | |
| KSAKQCKARWYEWLD | 41 | Q99459 | |
| KWEFTSWVPLVSKMC | 126 | Q6ZTN6 | |
| MEKLLRLCCWYSWLL | 1 | Q6QNK2 | |
| MLIKLWDWDKKWSCS | 121 | P35606 | |
| VCKEWYRVTSDGMLW | 211 | Q9Y297 | |
| DCLLKVWYPMTGWKS | 191 | Q8TDJ6 | |
| SYKIWKDDCLLMVWS | 931 | Q9UPM8 | |
| IYTSWIDCWCMLQKE | 261 | Q9Y6C9 | |
| RCKATIYLWKWDDKV | 626 | Q9BQK8 | |
| CIDMDWKVLTWLRYT | 266 | Q9P035 | |
| WCWELERTKGNMKYK | 211 | Q9C0I1 | |
| DSVWKYCWGVLMVLC | 6 | P52799 | |
| YIVCQLMEDLKWLWY | 221 | A6NFY4 | |
| MTAFCLFTWDKWLKV | 436 | Q6P1A2 | |
| NLEKVWDMLLEKWLC | 1811 | P50748 | |
| SADWSLEALLYKWDM | 136 | Q86XA0 | |
| MDRKWYFLCNSWLSI | 1481 | Q7Z442 | |
| KRMSKETWGYFCSKW | 2206 | Q7Z442 | |
| IQAIRCWTIWKYMKD | 71 | Q3SYC2 | |
| KEFTDIWMAVWASLC | 216 | Q9ULV1 | |
| WCFIKVTNDKVKWEY | 256 | Q14520 | |
| NPWMWSKCSRKYITE | 471 | Q9P2N4 | |
| CYVSITKIKKEWWDQ | 251 | P24394 | |
| WYSSSMKVICVWLTD | 1206 | Q86UW7 | |
| VKEYCRNDWSMWKVF | 101 | Q8N1N2 | |
| TDAIYDIILDMKWCW | 426 | Q9Y2H2 | |
| ELYVNKMKDKTLWRW | 946 | Q96RY7 | |
| VQYKKSTAWLWVRDM | 926 | Q5VW36 | |
| MDKYIHKRWALVWLA | 531 | Q8NAC3 | |
| LDWWSKYFASIDTMK | 1326 | Q9HC10 | |
| LHWWYDKKDNTCSMF | 91 | O95925 | |
| KLCDWWSLGVIMYEM | 301 | Q15208 | |
| NKLCDWWSLGVIMYE | 301 | Q9Y2H1 | |
| CDCKAKWLYLWLKMT | 171 | Q8N0V4 | |
| EWRKEMGLCWKEVAY | 356 | Q8NFW8 | |
| MESEYVLCNWKDQLW | 1 | Q5H9M0 | |
| DMTWDIKYKTVRWSF | 171 | Q9BRJ2 | |
| YMWIKAVKTGSICWA | 181 | P46977 | |
| WNLVSMCVEYVLLWK | 211 | Q9NP59 | |
| ELLKVWKGLFYCMWM | 51 | P56182 | |
| LWRKDKYDCLIWIMT | 461 | P40879 | |
| DLKMCHSDWKSGEYW | 1261 | P02452 | |
| ENMILRYVKAKADWW | 736 | Q6P2Q9 | |
| SSCYTLIWDLKMDWG | 521 | Q9UBH6 | |
| KYLIWDCCPMWVKLK | 641 | Q9Y5Y9 | |
| DWDKAWEITKKTCAY | 361 | P11216 | |
| KEWNLKYSVIKCWLA | 221 | Q5VVX9 | |
| MDTWLVCWAIFSLLK | 1 | A0A1B0GX68 | |
| DIEWKFARTKLWMSY | 636 | Q9UL62 | |
| VQLWALWAMYHVCSK | 686 | Q6WRX3 | |
| QKRWEYCNSLDMVKW | 136 | Q9UPU7 | |
| WRTGCYEKVKMWFDD | 186 | O75954 |